NACOGDOCHES, TX (News Release) - Few people would ever think the invasive water weed, giant salvinia could someday be the primary ingredient of a cancer-treating drug. That is unless you're Dr. Shiyou Li, research professor and director of SFA's National Center for Pharmaceutical Crops (NCPC)
A small team of researchers, Li's ability to think outside the box and invasive plants make up the formula to great discoveries.
"I strongly believe in the last many years such an invasive species may have a potential in medicinal application," said Li.
Giant salivinia is the unlikely weed to do good things. It's been cussed by fishermen for years.
"It takes away all the oxygen out of the water. It completely covers over the water," said Terry Sympson, a marina manager.
Mechanical harvest, biological control and herbicide application costs hundreds of thousands of dollars. Dr. Li suggests using the money for utilization as a control approach.
"And making profit and use it for production for human beings," said Li.
Dr Li already knows salvinia compounds in the purest form. It can shrink human tumor cells.
"More interestingly, the chemical compounds we isolated is less toxic to normal cells, human normal cells," said Li.
After the initial discovery, M.D. Anderson Cancer Clinic researchers joined in. They discovered the 30 something compounds have a unique molecular makeup.
Only $100,000 is needed to obtain the patent so further testing can begin. Further research will serve both fishermen and cancer patients alike.
©2011 KTRE. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
SFA News Service Press Release:
A thorn in the side of area boating enthusiasts may provide a ray of hope for some cancer patients, according to recent research findings at Stephen F. Austin State University's National Center for Pharmaceutical Crops.
Researchers at the center have discovered that giant salvinia, one of the most noxious invasive species in the world, has promising medical potential that could provide a novel approach to controlling the species.
The team recently discovered that extracts of giant salvinia can effectively inhibit the growth of human tumor cells with minimum damage to normal cells. The researchers are also the first to have isolated a class of compounds responsible for the bioactivities.
"Our research opens a new door to positive control of noxious invasive plants," said Dr. Shiyou Li, research professor and director of the center, which is housed in the Arthur Temple College of Forestry and Agriculture at SFA. "also, our elucidation of the chemical composition of giant salvinia will help researchers better understand the molecular mechanism of invasion."
Giant salvinia, also known as water fern and kariba weed and by its scientific name Salvinia molesta D. S. Mitchell, is a fern species native to Brazil. Since 1939, it has invaded lake and river systems in warm climates. Climate change, particularly increasing temperatures, a longer growing season and rising carbon dioxide levels, have increased both the abundance and diversity of invasive plants. Giant salvinia currently is one of the most widespread and environmentally, economically and socially destructive invasive plant species in the world.
Giant salvinia is able to double in number and biomass in less than three days in optimal conditions and forms dense mats on still waters. The plant can regenerate even after severe damage or drying. The explosive growth of giant salvinia not only adversely affects the natural ecological system of the infested region, but it also causes considerable economic damage and sanitation problems.
Dense mats of salvinia reduce dissolved oxygen levels and block all sunlight from penetrating the infested water body, causing macrophytes and microscopic algae that form the base of the food chain to die off. The animals that feed on the algae may die, too, and so on, up the food chain. This pest also threatens cultivated aquatic crops, and it can clog irrigation and drinking water lines and foul hydroelectric plants. Salvinia-infested waters cannot be used for boating or other recreational purposes.
Since 1980, the tiny salvinia weevil – cyrtobagous salviniae, curculionidae – has been introduced into most regions invaded by giant salvinia. The weevil is a strict specialist and has successfully controlled salvinia for years in some regions. Other attempts to control and eradicate salvinia through chemical and mechanical means have failed and may lead to an environmental backlash caused by the introduction of chemicals or bio agents into the ecosystem, Li said.
"For many years, i have promoted utilization as an effective and environmental approach to control invasive species," Li said. "I believe that positive actions such as identification of useful chemical components in existing invasive species and subsequent development of these species as medical or pharmaceutical crops would stimulate harvest and utilization."
Part of the NCPC project is funded by the National Institute of Food and Agriculture of the U.S. Department of Agriculture. Dr. Li is the principal investigator, while Drs. Ping Wang, Guangrui Deng and Wei Yuan participated in the research and were responsible for the primary isolation of the compounds.
Chris Moret of the Texas Parks and Wildlife Department and his crew have collected about 1,000 pounds of plant matter in East Texas for use in the study. To date, more than 30 different compounds, including four new compounds, have been isolated from the giant salvinia. Further tests of the bioactive compounds isolated from giant salvinia are ongoing in Dr. Bharat B. Aggarwal's lab in M.D. Anderson Cancer Center in Houston.
"Dr. Li and I have been discussing all the results we have jointly obtained with this plant, and it is looking extremely promising," said Aggarwal, a professor in the Department of Experimental Therapeutics, Division of Cancer Medicine, at M.D. Anderson.
"We are very excited about the potential that exists with it, especially in the area of cancer, and I am very optimistic about what could result from this collaboration."
Aggarwal added that securing funding for the continuing research is the biggest obstacle for the researchers to overcome in the short term. "Without funding, we can only do so much. So, that is going to be one of the limiting factors."
li said his team is grateful for the strong support their research has received from SFA's Board of Regents and Administration, the local community, and elected officials, including U.S. Sen. Kay Bailey Hutchison and U.S. Rep. Louie Gohmert. The National Center for Pharmaceutical Crops has received funds from the U.S. Department of Agriculture, Centers for Disease Control and Prevention, the Department of Education, SFA Research Development grants and private donations.
"I applaud Dr. Shiyou Li and his talented team of researchers and scientists for their innovative work right here in Texas to solve some of our country's most pressing scientific problems," Hutchison said.
"Under dr. Li's leadership, the National Center for Pharmaceutical Crops at SFA has helped bring texas to the forefront of medicinal plant research. Through their commitment to collaboration among a diverse range of fields from agriculture to biomedicine, they are achieving groundbreaking advancements in the treatment of many life-threatening diseases like cancer."
Dr. Steven h. Bullard, dean of the Arthur Temple College of Forestry and Agriculture, said pioneer studies at the NCPC have made SFA an international leader in researching pharmaceutical crops.
"In the last several years, the center has dedicated its research to identifying novel anticancer and antiviral agents from native plants in texas and noxious invasive species and to securing national strategic pharmaceuticals," he said. "The team has tested 1,200 plant species native to texas and isolated more than 600 compounds, including 106 new structures."
Li has developed the first high-yielding cultivar of anti-cancer camptotheca and trichome management technology to induce drug production. Both the cultivar and the technology have been granted patents. In 2005, his team identified leaves of Sweetgum as a high-yielding alternative source for imported shikimic acid. A limited supply of shikimic acid is the main reason for the global shortage of the antiviral drug Tamiflu.
Li and his colleagues at National Cancer Institute, M.D. Anderson Cancer Center, New York Botanical Garden and University of Puerto Rico have developed the concept and principle of pharmaceutical crops. With the support of a team of international leading scientists, most recently, they launched Pharmaceutical Crops, the only international peer-review journal in the field, with Bentham Science Publishers.